Your browser doesn't support javascript.
loading
Optimizing disease progression assessment using blinded central independent review and comparing it with investigator assessment in the PRIMA/ENGOT-ov26/GOG-3012 trial: challenges and solutions.
Herzog, Thomas J; Wahab, Shaun A; Mirza, Mansoor R; Pothuri, Bhavana; Vergote, Ignace; Graybill, Whitney S; Malinowska, Izabela A; York, Whitney; Hurteau, Jean A; Gupta, Divya; González-Martin, Antonio; Monk, Bradley J.
  • Herzog TJ; Department of Obstetrics and Gynecology, University of Cincinnati Cancer Center, Cincinnati, Ohio, USA thomas.herzog@uc.edu.
  • Wahab SA; Department of Radiology, University of Cincinnati Medical Center, Cincinnati, Ohio, USA.
  • Mirza MR; Department of Oncology, Nordic Society of Gynaecological Oncology Clinical Trial Unit (NSGO-CTU) and Rigshospitalet-Copenhagen University Hospital, Copenhagen, Denmark.
  • Pothuri B; Department of Obstetrics and Gynecology, NYU Langone Health Perlmutter Cancer Center, New York, New York, USA.
  • Vergote I; Department of Obstetrics and Gynecology, Leuven Cancer Institute, Catholic University Leuven, Leuven, Belgium.
  • Graybill WS; Department of Obstetrics and Gynecology, Medical University of South Carolina, Charleston, South Carolina, USA.
  • Malinowska IA; Oncology Research & Development, GSK, Waltham, Massachusetts, USA.
  • York W; Oncology Statistics, GSK, Upper Providence, Pennsylvania, USA.
  • Hurteau JA; Synthetic Lethality & Immuno-oncology, GSK, Waltham, Massachusetts, USA.
  • Gupta D; Synthetic Lethality, GSK, Waltham, Massachusetts, USA.
  • González-Martin A; Department of Medical Oncology, Grupo Español de Investigación en Cáncer de Ovario (GEICO), Program in Solid Tumors, Center for Applied Medical Research (CIMA), Madrid, Spain.
  • Monk BJ; Department of Obstetrics and Gynecology, HonorHealth Research Institute, University of Arizona College of Medicine, Phoenix, Arizona, USA.
Int J Gynecol Cancer ; 33(11): 1733-1742, 2023 11 06.
Article en En | MEDLINE | ID: mdl-37931976

Texto completo: 1 Ejes tematicos: Pesquisa_clinica Banco de datos: MEDLINE Asunto principal: Neoplasias Ováricas / Neoplasias Peritoneales Límite: Female / Humans Idioma: En Año: 2023 Tipo del documento: Article

Texto completo: 1 Ejes tematicos: Pesquisa_clinica Banco de datos: MEDLINE Asunto principal: Neoplasias Ováricas / Neoplasias Peritoneales Límite: Female / Humans Idioma: En Año: 2023 Tipo del documento: Article